BEATRIZ
ARRIZABALAGA AMUCHASTEGUI
Hospital Universitario La Fe
Valencia, EspañaPublications en collaboration avec des chercheurs de Hospital Universitario La Fe (11)
2020
-
Optimised molecular genetic diagnostics of Fanconi anaemia by whole exome sequencing and functional studies
Journal of Medical Genetics, Vol. 57, Núm. 4, pp. 258-268
2017
-
Clinical and biological significance of isolated Y chromosome loss in myelodysplastic syndromes and chronic myelomonocytic leukemia. A report from the Spanish MDS Group
Leukemia Research, Vol. 63, pp. 85-89
-
Enumerating bone marrow blasts from nonerythroid cellularity improves outcome prediction in myelodysplastic syndromes and permits a better definition of the intermediate risk category of the Revised International Prognostic Scoring System (IPSS-R)
American Journal of Hematology, Vol. 92, Núm. 7, pp. 614-621
-
Presence of acute and chronic renal failure in patients with paroxysmal nocturnal hemoglobinuria: results of a retrospective analysis from the Spanish PNH Registry
Annals of Hematology, Vol. 96, Núm. 10, pp. 1727-1733
2016
-
Considering bone marrow blasts from nonerythroid cellularity improves the prognostic evaluation of myelodysplastic syndromes
Journal of Clinical Oncology, Vol. 34, Núm. 27, pp. 3284-3292
-
Erythroleukemia shares biological features and outcome with myelodysplastic syndromes with excess blasts: A rationale for its inclusion into future classifications of myelodysplastic syndromes
Modern Pathology, Vol. 29, Núm. 12, pp. 1541-1551
-
Spanish consensus statement for diagnosis and treatment of paroxysmal nocturnal haemoglobinuria
Medicina Clinica
2015
-
Evolution of iron overload in patients with low-risk myelodysplastic syndrome: iron chelation therapy and organ complications
Annals of Hematology, Vol. 94, Núm. 5, pp. 779-787
2014
-
Multivariate time-dependent comparison of the impact of lenalidomide in lower-risk myelodysplastic syndromes with chromosome 5q deletion
British Journal of Haematology, Vol. 166, Núm. 2, pp. 189-201
2010
-
Deferasirox in iron-overloaded patients with transfusion-dependent myelodysplastic syndromes: Results from the large 1-year EPIC study
Leukemia Research, Vol. 34, Núm. 9, pp. 1143-1150
-
Iron overload and chelation therapy in patients with low-risk myelodysplastic syndromes with transfusion requirements
Annals of Hematology, Vol. 89, Núm. 2, pp. 147-154